R1	Has_temporal Arg1:T1 Arg2:T2	
R2	Has_temporal Arg1:T3 Arg2:T4	
R3	Has_qualifier Arg1:T5 Arg2:T6	
R4	AND Arg1:T3 Arg2:T5	
R5	multi Arg1:T9 Arg2:T10	
R6	Has_index Arg1:T8 Arg2:T9	
R7	Has_temporal Arg1:T7 Arg2:T8	
R8	Subsumes Arg1:T12 Arg2:T13	
*	OR T15 T16 T17 T18 T19
R9	Subsumes Arg1:T14 Arg2:T15	
*	OR T11 T12 T14
R10	Subsumes Arg1:T7 Arg2:T11	
R11	Has_qualifier Arg1:T26 Arg2:T25	
R12	AND Arg1:T22 Arg2:T23	
R13	AND Arg1:T22 Arg2:T24	
*	OR T32 T33
*	OR T31 T30
R14	AND Arg1:T31 Arg2:T32	
R15	Has_qualifier Arg1:T36 Arg2:T37	
R16	Has_negation Arg1:T38 Arg2:T39	
R17	AND Arg1:T40 Arg2:T38	
R18	Has_value Arg1:T41 Arg2:T42	
R19	Has_context Arg1:T40 Arg2:T41	
R20	Has_mood Arg1:T45 Arg2:T47	
*	OR T43 T46 T44
R21	AND Arg1:T44 Arg2:T45	
R22	Has_negation Arg1:T51 Arg2:T50	
*	OR T48 T49
R23	Has_temporal Arg1:T53 Arg2:T54	
R24	AND Arg1:T55 Arg2:T52	
R25	Has_temporal Arg1:T59 Arg2:T58	
R26	AND Arg1:T59 Arg2:T60	
R27	Has_temporal Arg1:T62 Arg2:T61	
*	OR T64 T65
R28	Subsumes Arg1:T63 Arg2:T64	
*	OR T68 T72 T70 T69 T71
R29	Subsumes Arg1:T67 Arg2:T68	
R30	AND Arg1:T22 Arg2:T26	
T1	Observation 11 33	enrolled in this study
T2	Temporal 0 10	Previously
T3	Procedure 86 104	surgical procedure
T4	Temporal 74 85	Concomitant
T5	Procedure 116 120	CABG
T6	Qualifier 105 115	other than
T7	Procedure 122 145	Anticoagulant treatment
T8	Temporal 146 165	after the operation
T9	Reference_point 152 165	the operation
T10	Procedure 156 165	operation
T11	Drug 172 180	warfarin
T12	Drug 182 208	direct thrombin inhibitors
T13	Drug 210 220	dabigatran
T14	Drug 223 237	FXa inhibitors
T15	Drug 239 250	rivaroxaban
T16	Drug 252 260	apixaban
T17	Drug 262 269	heparin
T18	Drug 271 299	low-molecular weight heparin
T19	Drug 301 313	fondaparinux
T22	Observation 316 325	Discharge
T23	Visit 335 353	operating hospital
T24	Visit 360 363	ICU
T25	Qualifier 367 374	another
T26	Visit 375 383	hospital
T28	Condition 385 394	Pregnancy
T29	Condition 398 407	lactation
T30	Condition 430 446	contraindication
T31	Condition 415 426	intolerance
T32	Drug 450 460	ticagrelor
T33	Drug 464 467	ASA
T36	Condition 473 481	disorder
T37	Qualifier 487 521	may interfere with drug absorption
T38	Condition 548 571	coronary artery disease
T39	Negation 537 547	other than
T40	Condition 527 536	condition
T41	Observation 579 594	life expectancy
T42	Value 595 605	<12 months
T43	Condition 613 634	chronic liver disease
T44	Condition 636 649	renal disease
T45	Procedure 660 668	dialysis
T46	Condition 672 689	bleeding disorder
T47	Mood 650 659	requiring
T48	Condition 691 716	Atrioventricular block II
T49	Condition 691 713;721 724	Atrioventricular block III
T50	Negation 737 744	without
T51	Device 745 754	pacemaker
T52	Condition 781 806	dual antiplatelet therapy
T53	Procedure 820 838	stent implantation
T54	Temporal 813 819	recent
T55	Condition 766 776	indication
T58	Temporal 860 891	within 90 days before inclusion
T59	Condition 853 859	stroke
T60	Condition 840 852	Debilitating
T61	Temporal 893 901	Previous
T62	Procedure 902 923	intracranial bleeding
T63	Drug 940 958	immunosuppressants
T64	Drug 965 977	cyclosporine
T65	Drug 982 992	tacrolimus
T67	Drug 1010 1034	strong CYP3A4-inhibitors
T68	Drug 1041 1053	ketoconazole
T69	Drug 1055 1069	clarithromycin
T70	Drug 1071 1081	nefazodone
T71	Drug 1083 1092	ritonavir
T72	Drug 1096 1106	atazanavir
T74	Non-query-able 1109 1209	Any condition that in the opinion of the investigator may interfere with adherence to trial protocol
